Prospective randomized clinical trial for effect of stellate ganglion block in medically refractory ventricular tachycardia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003955

Enrollment

Registered

2019-05-21

Start date

2019-06-14

Completion date

Unknown

Last updated

2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : 1. Research registration for medically refractory ventricular tachycardia 2. Treatment of Antiarrhythmic drug in both the experimental group and the control group 3. In addition, t

Study Arms &gt

•Experimental : Antiarrhythmic drug + percutaneous stellate ganglion block •Active Comparator : Antiarrhythmic drug group 4. Treat according to assigned group 5. Additional treatments are performed t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Over 19 years old or The legal age at which consent for the target can be provided under national law. 2. Patient are diagnosed Refractory Ventricular tachycardia - Patients who have generated Refractory Ventricular tachycardia despite of defibrillation and drug therapy - Patients with ICD have generated ICD shock or anti-tachycardia pacing despite of defibrillation and drug therapy

Exclusion criteria

Exclusion criteria: 1. Patients who do not agree with study inclusion 2. Patients who do not taken stellate ganglion block due to unstable hemodynamic status 3. Patients have experienced major hemorrhagic complication 4. Patients of the DNR(do not resuscitate) status 5. Patients with malignancy tumor, major neurogenic disease or gastrointestinal disease

Design outcomes

Primary

Measure	Time frame
Comparison of frequency changes in persistent ventricular fibrillation that occurred 24 hours before and after treatment began in each group.;Comparison of Frequency Changes in persistent ventricular fibrillation in 5 Days in each group	—

Secondary

Measure	Time frame
mortality;For ICD(implantable cardioverter defibrillator) patients, anti - tachycardia + shock occurrence and frequency;major complication related to stellate ganglion block.	—

Countries

Korea, Republic of

Contacts

Public Contactsohee Joo

Yonsei University Health System, Severance Hospital

shjoo95@yuhs.ac+82-2-2228-8528

Outcome results